Matthew Sinnreich - 31 Oct 2022 Form 4/A - Amendment Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
President and Acting CEO, Director
Signature
/s/ Dale S. Bergman as attorney-in-fact for Matthew Sinnreich
Issuer symbol
OCEL
Transactions as of
31 Oct 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
03 Nov 2022, 17:01:38 UTC
Date Of Original Report
01 Nov 2022
Previous filing
17 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock, $0.001 par value Other -6,976,000 -100% 0 31 Oct 2022 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 31, 2022, the Reporting Person relinquished his ownership interest in Retrograde Investments, LLC, which held the shares of common stock reported hereunder. As a result, the Reporting Person no longer exercises any voting or and dispositive power over such shares.